TB persists despite cure and vaccine; slow research and complex biology hinder progress

Tuberculosis remains a leading infectious killer despite a decades-old cure and vaccine, largely because Mycobacterium tuberculosis grows slowly, complicating research and drug development. The article highlights the scientific challenges, not a new outbreak or policy change, and underscores the ongoing global health burden.